Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects.

D V Milford, C M Taylor, B Guttridge, S M Hall, B Rowe, H Kleanthous

Department of Nephrology, Children's Hospital, Birmingham.

A prospective study of the clinical and epidemiological features of the haemolytic uraemic syndromes was conducted over a three year period in the British Isles. Two hundred and ninety eight children were reported. In two thirds of cases stool samples were analysed for the presence of Verocytotoxin producing Escherichia coli (VTEC) and neutralisable Verocytotoxin. A total of 273 (95%) patients had a prodrome of diarrhoea. In these a seasonal variation in the incidence of haemolytic uraemic syndrome was demonstrated, the 1-2 year age range was most often affected, and the peripheral blood neutrophil count correlated positively with an adverse outcome. Patients presenting without diarrhoea showed none of these associations and had a significantly greater morbidity and mortality. Evidence for VTEC infection was found in 58 (33%) of 178 diarrhoea associated cases whose stools were analysed, although VTEC were identified in five of eight (62%) patients whose stools were collected within three days of the onset of diarrhoea. Most isolates produced VT2 either alone, or together with VT1. There was no evidence of VTEC infection in patients without prodromal diarrhoea.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Gender and the progression of Escherichia coli O157:H7 enteritis to haemolytic uraemic syndrome.

N Cimolai and J E Carter
Arch. Dis. Child. 1991 66: 171-172. [PDF]

This article has been cited by other articles:

• Krautz-Peterson, G., Chapman-Bonofiglio, S., Boisvert, K., Feng, H., Herman, I. M., Tzipori, S., Sheoran, A. S. (2008). Intracellular Neutralization of Shiga Toxin 2 by an A Subunit-Specific Human Monoclonal Antibody. Infect. Immun. 76: 1931-1939 [Abstract] [Full Text]  
• Kitova, E. N, Kitov, P. I, Paszkiewicz, E., Kim, J., Mulvey, G. L, Armstrong, G. D, Bundle, D. R, Klassen, J. S (2007). Affinities of Shiga toxins 1 and 2 for univalent and oligovalent Pk-trisaccharide analogs measured by electrospray ionization mass spectrometry. Glycobiology 17: 1127-1137 [Abstract] [Full Text]  
• Flagler, M. J., Strasser, J. E., Chalk, C. L., Weiss, A. A. (2007). Comparative Analysis of the Abilities of Shiga Toxins 1 and 2 To Bind to and Influence Neutrophil Apoptosis. Infect. Immun. 75: 760-765 [Abstract] [Full Text]  
• Suri, R. S., Clark, W. F., Barrowman, N., Mahon, J. L., Thiessen-Philbrook, H. R., Rosas-Arellano, M. P., Zarnke, K., Garland, J. S., Garg, A. X. (2005). Diabetes During Diarrhea-Associated Hemolytic Uremic Syndrome: A systematic review and meta-analysis. Diabetes Care 28: 2556-2562 [Abstract] [Full Text]  
• Sheoran, A. S., Chapman-Bonofiglio, S., Harvey, B. R., Mukherjee, J., Georgiou, G., Donohue-Rolfe, A., Tzipori, S. (2005). Human Antibody against Shiga Toxin 2 Administered to Piglets after the Onset of Diarrhea Due to Escherichia coli O157:H7 Prevents Fatal Systemic Complications. Infect. Immun. 73: 4607-4613 [Abstract] [Full Text]  
• Tzipori, S., Sheoran, A., Akiyoshi, D., Donohue-Rolfe, A., Trachtman, H. (2004). Antibody Therapy in the Management of Shiga Toxin-Induced Hemolytic Uremic Syndrome. Clin. Microbiol. Rev. 17: 926-941 [Abstract] [Full Text]  
• Pearce, M. C., Jenkins, C., Vali, L., Smith, A. W., Knight, H. I., Cheasty, T., Smith, H. R., Gunn, G. J., Woolhouse, M. E. J., Amyes, S. G. B., Frankel, G. (2004). Temporal Shedding Patterns and Virulence Factors of Escherichia coli Serogroups O26, O103, O111, O145, and O157 in a Cohort of Beef Calves and Their Dams. Appl. Environ. Microbiol. 70: 1708-1716 [Abstract] [Full Text]  
• Sheoran, A. S., Chapman, S., Singh, P., Donohue-Rolfe, A., Tzipori, S. (2003). Stx2-Specific Human Monoclonal Antibodies Protect Mice against Lethal Infection with Escherichia coli Expressing Stx2 Variants. Infect. Immun. 71: 3125-3130 [Abstract] [Full Text]  
• Cummings, K. C., Mohle-Boetani, J. C., Werner, S. B., Vugia, D. J. (2002). Population-based Trends in Pediatric Hemolytic Uremic Syndrome in California, 1994-1999: Substantial Underreporting and Public Health Implications. Am J Epidemiol 155: 941-948 [Abstract] [Full Text]  
• TAGUCHI, H., TAKAHASHI, M., YAMAGUCHI, H., OSAKI, T., KOMATSU, A., FUJIOKA, Y., KAMIYA, S. (2002). Experimental infection of germ-free mice with hyper-toxigenic enterohaemorrhagic Escherichia coli O157:H7, strain 6. J Med Microbiol 51: 336-343 [Abstract] [Full Text]  
• George, J. N., Sadler, J. E., Lammle, B. (2002). Platelets: Thrombotic Thrombocytopenic Purpura. ASH Education Book 2002: 315-334 [Abstract] [Full Text]  
• Nakajima, H., Kiyokawa, N., Katagiri, Y. U., Taguchi, T., Suzuki, T., Sekino, T., Mimori, K., Ebata, T., Saito, M., Nakao, H., Takeda, T., Fujimoto, J. (2001). Kinetic Analysis of Binding between Shiga Toxin and Receptor Glycolipid Gb3Cer by Surface Plasmon Resonance. J. Biol. Chem. 276: 42915-42922 [Abstract] [Full Text]  
• Elliott, E J, Robins-Browne, R M, O'Loughlin, E V, Bennett-Wood, V, Bourke, J, Henning, P, Hogg, G G, Knight, J, Powell, H, Redmond, D, Contributors to the Australian Paediatric Surveill, (2001). Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch. Dis. Child. 85: 125-131 [Abstract] [Full Text]  
• Armon, K, Stephenson, T, MacFaul, R, Eccleston, P, Werneke, U, BAUMER, H. (2001). An evidence and consensus based guideline for acute diarrhoea management. Arch. Dis. Child. 85: 132-142 [Abstract] [Full Text]  
• Hirao, I., Madin, K., Endo, Y., Yokoyama, S., Ellington, A. D. (2000). RNA Aptamers That Bind to and Inhibit the Ribosome-inactivating Protein, Pepocin. J. Biol. Chem. 275: 4943-4948 [Abstract] [Full Text]  
• Fitzpatrick, M. (1999). Haemolytic uraemic syndrome and E coli 0157 . BMJ 318: 684-685 [Full Text]  
• Paton, J. C., Paton, A. W. (1998). Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections. Clin. Microbiol. Rev. 11: 450-479 [Abstract] [Full Text]  
• Taylor, C M, Monnens, L A H (1998). Advances in haemolytic uraemic syndrome. Arch. Dis. Child. 78: 190-193 [Full Text]  
• Neuhaus, T. J, Calonder, S., Leumann, E. P (1997). Heterogeneity of atypical haemolytic uraemic syndromes. Arch. Dis. Child. 76: 518-521 [Abstract] [Full Text]